NMSC Coverage From Every Angle
Advertisement
Advertisement

Recent News

Skin Cancer Among Childhood Cancer Survivors
FDA Proposes Updated Requirements for Sunscreen Products
Skin Cancer Incidence in Patients Receiving Multiple Kidney Transplants
Identifying Rare Genetic Tumor Syndrome Affecting the Skin
Updated German Guidelines for Basal Cell Carcinoma
Primary Cutaneous Lymphomas: Update of WHO-EORTC Classification
New Treatment of Resistant S├ęzary Syndrome Granted FDA Fast Track Designation
Apoptotic Responses Triggered in Dual-Targeted Virus-Positive Merkel Cell Carcinomas
Clinical Predictors of Merkel Cell Carcinoma: Ulceration and Hyperkeratosis
Pilot Study of Toll-Like Receptor 4 Agonist in Merkel Cell Carcinoma
Srcasm Levels: Potential Therapeutic Target in Skin Cancer
Pembrolizumab Approved for Merkel Cell Carcinoma by the FDA
Incidence of Metastatic Cutaneous Squamous Cell Carcinoma in England
Is Rare Genetic Disorder Linked to Development of Squamous Cell Skin Cancer?
Definitive HDR Brachytherapy for Non-Melanoma Skin Cancer
Update on Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma
Avelumab: JAVELIN Merkel 200 Trial Translated to Real World
ESMO 2018: Evaluating Response to Avelumab in Metastatic Merkel Cell Carcinoma
ESMO 2018: Cetuximab in Unresectable Cutaneous Squamous Cell Carcinoma
Novel Models for Predicting Skin Cancer Risk
ESMO 2018: Sonidegib Treatment in Advanced Basal Cell Carcinoma
Novel Mechanism of Resistance Identified in Merkel Cell Carcinoma
Is There a Correlation Between Azathioprine and Skin Cancer Development?
Can Artificial Neural Network Help Predict Non-Melanoma Skin Cancer?
FDA Approves Cemiplimab for Metastatic Cutaneous Squamous Cell Carcinoma
Are Current Staging Systems for Cutaneous Squamous Cell Carcinoma Satisfactory?


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.